抗血小板单一疗法用于皮肤冠状动脉干预后的长期二次预防
Claudio Laudani1,2, Daniele Giacoppo1, Antonio Greco1
1Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "Rodolico-San Marco", University of Catania, 95124 Catania, Italy.
Journal of clinical medicine
|August 14, 2025
概括
双抗血小板疗法 (DAPT) 是冠状动脉疾病 (CAD) 患者皮肤穿冠状动脉干预 (PCI) 后的标准. 单独使用P2Y12抑制剂显示有望降低出血风险而不会增加缺血事件.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 干预心脏病学 干预心脏病学
背景情况:
- 双重抗血小板疗法 (DAPT),包括阿司匹林和P2Y12抑制剂,是冠状动脉疾病 (CAD) 患者皮肤外冠状动脉干预 (PCI) 后的二次预防的标准.
- 目前的指导方针建议DAPT持续6-12个月,但PCI技术和药理学的进步促使重新评估长期DAPT的必要性.
研究的目的:
- 在CAD患者中审查长期抗血小板治疗背后的逻辑.
- 讨论长期使用P2Y12抑制剂单疗的药理学.
- 要总结当前的证据,比较PCI后的不同长期抗血小板单一疗法.
主要方法:
- 在CAD患者中评估抗血小板治疗的研究的文献综述.
- 支持P2Y12抑制剂单疗法与DAPT和阿司匹林单疗法的证据分析.
- 对抗血小板药物长期使用的药理性质的检查.
主要成果:
- 与标准DAPT相比,P2Y12抑制剂单疗法,特别是蒂卡格勒勒,在短时间的DAPT疗程后,可以减少出血事件,而不会影响缺血性保护.
- 长期P2Y12抑制剂单疗法超过PCI后第一年的证据越来越多,但不如阿司匹林单疗法那么强大.
- 阿司匹林单一治疗仍然是许多CAD患者长期二次预防的主要策略.
结论:
- 单独使用P2Y12抑制剂是降低PCI后CAD患者出血风险的可行策略,具有长期二次预防的潜力.
- 需要进一步的可靠数据来确定最佳的长期抗血小板策略,特别是比较不同单一治疗药物超出最初的PCI后期.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:26Angina IV: Management
22
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
22
01:28Acute Coronary Syndrome IV: Interprofessional Care
27
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
27
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22